Healthcare start-ups can be smart and agile, but even cutting-edge innovations can fail without clinical context. The iHub’s 2014 Pilot Shark Tank brought Twine Health into Brigham and Women’s Hospital last year, enabling exactly this type of (necessary) clinical validation. Read about Twine Health’s major milestone earlier this month, closing their $6.7M Series A round:
MIT Media Lab spin-out Twine Health has raised $6.75 million to support the expansion of a software platform using apps to help patients manage their chronic diseases and collaborate with physicians. Since the company scored a clinical collaboration as part of a digital health pitch contest at Brigham and Women’s Hospital iHub innovation center last year, it has been validating its approach in clinical trials and building its platform for large-scale commercial deployment.
The institutional investors that participated in the Series A round included Khosla Ventures, Provenance Venture Forum, and Tower Capital Partners. Other round participants were Andy Palmer, James Pallotta and retired Genzyme CEO Henri Termeer.
Among its target customers are primary care practices, Accountable Care Organizations and on-site employer clinics.
Read the full article here.